WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Aug 15, 2025, 12:21 PM
3.90
-2.50%
After-hours: Aug 13, 2025, 08:00 PM EDT

WuXi Biologics (Cayman) Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.28B 9.67B 6.4B 9B
Short-Term Investments
2.43B 1.57B 2.32B 2.12B
Long-Term Investments
-30.78M 2.93B 390.11M 79.62M
Other Long-Term Assets
2.58B 461.97M 2.49B 2.32B
Receivables
5.79B 6.25B 5.16B 3.27B
Inventory
1.52B 1.77B 2.28B 1.69B
Other Current Assets
5.47B 1.83B 2.32B 3.44B
Total Current Assets
23.57B 21.2B 18.47B 19.53B
Property-Plant & Equipment
28.44B 29.94B 25.92B 19.76B
Goodwill & Intangibles
1.97B 2.04B 2.08B 2.13B
Total Long-Term Assets
33.4B 35.38B 31.09B 24.5B
Total Assets
56.98B 56.58B 49.56B 44.03B
Account Payables
747.15M 833.27M 794.39M 617.78M
Deferred Revenue
n/a 430.48M n/a n/a
Short-Term Debt
2.44B 576.33M 1.32B 2.12B
Other Current Liabilities
2.58B 4.84B 6.06B 4.56B
Total Current Liabilities
8.62B 7.64B 9.32B 8.26B
Long-Term Debt
200.9M 1.57B 1.46B 640.51M
Other Long-Term Liabilities
n/a 1.09B n/a n/a
Total Long-Term Liabilities
2.88B 4.92B 4.03B 3.07B
Total Liabilities
11.5B 12.56B 13.35B 11.33B
Total Debt
4.94B 4.56B 4.42B 4.3B
Common Stock
226K 235K 233K 235K
Retained Earnings
16.36B 14.98B 11.58B 7.16B
Comprehensive Income
n/a 1.78B 1.37B 593.13M
Shareholders Equity
41.82B 40.33B 35.05B 32.28B
Total Investments
2.4B 2.93B 2.71B 2.2B